Ceftriaxone (plain & combinations) Injection PCD Franchise Company in India
BIOFRIL HEALTHCARE is a WHO-GMP certified manufacturer and Ceftriaxone (plain & combinations) PCD franchise company in India. We supply Ceftriaxone (plain & combinations) (third-generation cephalosporin) under monopoly district rights with COA-backed batches, tender-ready documentation and dispatch from our Nalagarh (Himachal Pradesh) facility.
Ceftriaxone (plain & combinations) — Clinical Role
Ceftriaxone (plain & combinations) is a third-generation cephalosporin used in lower respiratory tract infections, enteric fever, surgical prophylaxis, meningitis, septicaemia and gonococcal infections. Quality of the lyophilized/finished form, cold-chain discipline where indicated, and batch documentation are what hospitals and drug inspectors check first — and where Biofril’s WHO-GMP process stands out.
Biofril Brands for Ceftriaxone (plain & combinations)
- RILCEFTA-1000 — 1 g vial
- RILCEFTA-250 — 250 mg vial
- RILCEFTA-S-1500 — Ceftriaxone + Sulbactam 1.5 g
- RILCEFTA-S-750 — Ceftriaxone + Sulbactam 750 mg
Why the Ceftriaxone (plain & combinations) Segment Is Worth Your Franchise
Ceftriaxone is India’s workhorse injectable antibiotic across every hospital tier — plain and sulbactam combinations cover both GP-nursing-home and ICU demand. With monopoly allocation, you face no internal competition in your district.
What You Get as a Biofril Partner
- Monopoly district rights documented in the agreement
- COA with every batch + WHO-GMP plant documentation for hospital and government tenders
- Promotional kit — visual aids, MR kits, doctor samples, scientific literature, net rate lists
- Manageable MOQ and one-business-day commercial response
- Full critical-care basket — combine Ceftriaxone (plain & combinations) with our complete injectable range under one agreement: Critical Care PCD Franchise
How to Start
- Share your district and current network via the enquiry form, +91 97658 93730 or WhatsApp.
- Receive net rates, product dossier and territory confirmation within one business day.
- Execute the monopoly agreement, place the inaugural order, receive stock + promo kit.
Who Buys Ceftriaxone in Your District
Ceftriaxone is the highest-volume hospital injectable antibiotic in most Indian districts. It is used from 20-bed nursing homes to tertiary hospitals, which makes it the easiest entry product for a new critical care PCD partner.
- Casualty and emergency departments — first-dose antibiotic for suspected serious infections.
- Medicine wards — community-acquired pneumonia, enteric fever and other systemic infections.
- Surgery, orthopaedics and obstetrics — surgical prophylaxis and post-operative infections in many hospitals.
- Paediatric wards — the reason a 250 mg vial (RILCEFTA-250) is needed alongside 1 g.
- Nursing homes and small hospitals — a large, under-served buyer base in tier-2 and tier-3 districts. See our small-district playbook.
How to Compete in a Crowded Molecule
Ceftriaxone has many brands, so price alone is a weak position. Partners who win usually combine three things:
- Range depth — plain ceftriaxone (1 g and 250 mg) plus ceftriaxone + sulbactam (RILCEFTA-S 1.5 g and 750 mg), so one supplier covers every protocol.
- Documentation — WHO-GMP manufacturing and a Certificate of Analysis for every batch, which hospital pharmacies increasingly ask for.
- Supply consistency — ceftriaxone is ordered weekly; stock-outs lose the account faster than a small price difference.
Stocking and Compliance Checklist
- Third-generation cephalosporins fall under Schedule H1, which requires a separate sale register — follow the label marking and State Drugs Control rules.
- Ceftriaxone is in the WHO AWaRe Watch group; many hospital antibiotic policies define where it is used first-line.
- Store dry powder vials as printed on the label; protect from heat and moisture in transit.
- Keep a higher safety stock than for other injectables because ceftriaxone rotates fastest.
Build a Basket Around Ceftriaxone
Ceftriaxone opens the door; the rest of the hospital list follows. Add IV pantoprazole, amikacin, hydrocortisone for emergency trays and piperacillin-tazobactam for ICUs. Browse the full critical care range or the anti-infectives PCD division.
FAQs — Ceftriaxone (plain & combinations) PCD Franchise
Do I need a drug licence?
Yes — Form 20B/21B wholesale licence and GST registration. We guide first-time applicants.
Is Ceftriaxone (plain & combinations) supplied with tender documentation?
Yes — WHO-GMP certificates, COAs and product dossiers are prepared in advance for institutional and GeM tenders.
Can I take only Ceftriaxone (plain & combinations) or the full injectable range?
Both are possible; most partners take the complete critical-care basket for better prescriber coverage and freight economics.
Which territories are open?
District-level monopoly availability is confirmed within one business day of your enquiry.
Is ceftriaxone a good first product for a new PCD distributor?
Yes. It is used in almost every hospital and nursing home, so it helps you open accounts quickly; margins depend on your rate list, so compare PTR and PTS before ordering.
What is the difference between ceftriaxone and ceftriaxone + sulbactam?
Sulbactam is a beta-lactamase inhibitor added to extend activity against some resistant organisms. Hospitals use both, depending on their antibiotic policy.
Which ceftriaxone strengths should I stock?
Most demand is for the 1 g vial; keep 250 mg for paediatrics and the sulbactam combinations (1.5 g and 750 mg) for hospitals that use them.
Apply Now — Ceftriaxone (plain & combinations) Injection PCD Franchise & Supplier India
Share your details — our franchise team will call you back with the product list, franchise rates and monopoly-area availability for your district.